Insider Buying: Motus GI Holdings Inc (MOTS) CEO Acquires 5,000 Shares of Stock

Motus GI Holdings Inc (NASDAQ:MOTS) CEO Timothy P. Moran purchased 5,000 shares of the firm’s stock in a transaction on Wednesday, May 22nd. The stock was bought at an average cost of $3.38 per share, for a total transaction of $16,900.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Shares of MOTS traded down $0.04 during mid-day trading on Friday, hitting $3.36. 41,841 shares of the company’s stock traded hands, compared to its average volume of 55,593. The company has a debt-to-equity ratio of 0.05, a quick ratio of 6.31 and a current ratio of 6.36. Motus GI Holdings Inc has a 1 year low of $2.34 and a 1 year high of $10.66. The stock has a market capitalization of $72.07 million, a PE ratio of -2.73 and a beta of 2.04.

Motus GI (NASDAQ:MOTS) last posted its earnings results on Friday, May 10th. The company reported ($0.29) earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.29). Research analysts forecast that Motus GI Holdings Inc will post -1.13 EPS for the current fiscal year.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Renaissance Technologies LLC bought a new stake in shares of Motus GI during the third quarter valued at approximately $139,000. IPG Investment Advisors LLC boosted its position in shares of Motus GI by 22.7% during the fourth quarter. IPG Investment Advisors LLC now owns 36,500 shares of the company’s stock valued at $114,000 after purchasing an additional 6,750 shares in the last quarter. Eaton Vance Management boosted its position in shares of Motus GI by 75.0% during the fourth quarter. Eaton Vance Management now owns 70,000 shares of the company’s stock valued at $218,000 after purchasing an additional 30,000 shares in the last quarter. Maven Securities LTD bought a new stake in shares of Motus GI during the fourth quarter valued at approximately $167,000. Finally, Nantahala Capital Management LLC bought a new stake in shares of Motus GI during the fourth quarter valued at approximately $1,555,000. 37.33% of the stock is currently owned by hedge funds and other institutional investors.

Several equities analysts have recently issued reports on MOTS shares. Zacks Investment Research raised Motus GI from a “hold” rating to a “buy” rating and set a $4.50 target price on the stock in a research note on Tuesday, January 29th. Oppenheimer set a $10.00 target price on Motus GI and gave the company a “buy” rating in a research note on Thursday, March 28th. ValuEngine cut Motus GI from a “buy” rating to a “hold” rating in a research note on Thursday. Finally, Piper Jaffray Companies reduced their target price on Motus GI from $8.00 to $6.00 in a research note on Friday, May 10th. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Motus GI presently has a consensus rating of “Buy” and a consensus price target of $9.17.

ILLEGAL ACTIVITY WARNING: This article was first posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are reading this article on another domain, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this article can be read at https://www.baseballdailydigest.com/news/2019/05/25/insider-buying-motus-gi-holdings-inc-mots-ceo-acquires-5000-shares-of-stock.html.

About Motus GI

Motus GI Holdings, Inc operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.

Featured Story: Why do companies issue convertible shares?

Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.